![Richard Shea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Shea
Directeur/Membre du Conseil chez
SYNLOGIC, INC.
Fortune : 18 840 $ au 31/08/2026
Profil
Richard P.
Shea is currently a Director at Synlogic Operating Co., Inc., an Independent Director at Synlogic, Inc. since 2017, and a Principle at Danforth Advisors LLC.
Formerly, Mr. Shea was Vice President-Finance at Genetics Institute LLC from 1992 to 1999, Chief Operating & Financial Officer at Variagenics, Inc. from 1999 to 2003, Chief Financial Officer & Senior Vice President at Momenta Pharmaceuticals, Inc. from 2015 to 2016, and CFO, Treasurer & Principal Accounting Officer at Syndax Pharmaceuticals, Inc. from 2017 to 2020.
Education includes an MBA from Boston University and an undergraduate degree from Princeton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYNLOGIC INC 0,13% | 31/03/2026 | 15 506 ( 0,13% ) | 18 840 $ | 31/08/2026 |
Postes actifs de Richard Shea
| Sociétés | Poste | Début |
|---|---|---|
| SYNLOGIC, INC. | Directeur/Membre du Conseil | 28/08/2017 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | - |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic biotechnology consulting services for corporate, clinical & commercial sectors | Corporate Officer/Principal | - |
Anciens postes connus de Richard Shea
| Sociétés | Poste | Fin |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur Financier/CFO | 13/07/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/12/2016 |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies related to pharmaco-genomics | Directeur Financier/CFO | 01/04/2003 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Financier/CFO | 01/01/1999 |
Formation de Richard Shea
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Variagenics, Inc.
Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies related to pharmaco-genomics | Commercial Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic biotechnology consulting services for corporate, clinical & commercial sectors | Commercial Services |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
